MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Pain Therapeutics (NASDAQ: PTIE)
Organization & Developments: Pain Therapeutics
Parents
Pain Therapeutics (NASDAQ: PTIE)
Children
2016: FDA rejects Pain Therapeutics' Remoxy ER marketing application; shares plummet 67% premarket - Pain Therapeutics (NASDAQ:PTIE)
2016: For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million
2018: FDA declines to approve Pain Therapeutics' opioid drug, shares plunge
2018: Pain Therapeutics endures yet another FDA slapdown on Remoxy
Jumps
*Key People: Pain Therapeutics
Finance & Acquisition: Pain Therapeutics